This action might not be possible to undo. Are you sure you want to continue?
LE Magazine September 2005
How Many Americans Are Magnesium Deficient?
I continue to be astonished by the scientific skill displayed by Life Extension members. Paul Mason is one such individual. Paul Mason has painstakingly documented that a significant cause of cardiovascular disease is magnesium deficiency. His mission has been to persuade the world that consuming more magnesium would stave off today’s leading cause of death: heart attack and stroke. Paul sued the FDA and Justice Department to mandate that all bottled water and soft drinks be fortified with magnesium.1 His rationale is that adding magnesium to bottled drinks would provide most Americans with the government’s recommended daily intake of this lifesaving mineral. This is by William Faloon analogous to the iodine deficiency that existed 70 years ago. After iodine was added to table salt, thyroid disease caused by iodine deficiency virtually disappeared.2-5 Paul wanted a federal court to order the FDA to inform the public about the critical need to ingest adequate magnesium, his reasoning being that the FDA is the agency with the resources and authority to get out this critically important health information.
To document his scientific position, Paul set up a website containing hundreds of published papers showing how magnesium prevents heart attack.6 The website also has excerpts from medical textbooks explaining why magnesium is so crucial to vascular health. Before the Internet became popular, Paul Mason compiled this data into huge books that he sent at his expense to anyone he thought was willing to spread the word about this lifesaving information. Until now, nutritional doctors thought they understood why magnesium was so beneficial to heart health. Magnesium had been shown to help lower blood pressure, correct arrhythmia, prevent coronary atherosclerosis, inhibit arterial blood clotting, improve exercise duration, and reduce cardiac mortality.7-30 A recent study demonstrates a new mechanism that further explains how magnesium could have saved millions of lives a year.3133 The reason I say could have saved millions of lives is that the government did everything it could to keep Americans from learning about the lifesaving properties of this virtually no-cost mineral.
AN EPIDEMIC DEFICIENCY
For decades, statisticians have demonstrated that the majority of Americans do not get the government’s minimum daily requirement for magnesium. The latest government study shows a staggering 68% of Americans do not consume the recommended daily intake of magnesium. Even more frightening are data from this study showing that 19% of Americans do not consume even half of the government’s recommended daily intake of magnesium.34 Is it any wonder that disability and death from heart attack and stroke are the nation’s leading killers? While the government officially refuses to recognize the effects of magnesium in preventing vascular disease, the National Institutes of Health does publish the following on its website: “Magnesium is needed for more than 300 biochemical reactions in the body. It helps maintain normal muscle and nerve function, keeps heart rhythm steady, supports a healthy immune system, and keeps bones strong. Magnesium also helps regulate blood sugar levels, promotes normal blood pressure, and is known to be involved in energy metabolism and protein synthesis. There is an increased interest in the role of magnesium in preventing and managing disorders such as hypertension, cardiovascular disease, and diabetes.”35
Tap water can be a source of magnesium. delivered within two hours of the appearance of stroke symptoms. because it cannot be patented.124-129 and fish oil. but the amount varies according to the water supply.139 Ingest magnesium at levels above the government’s recommended daily intake.130-138 Maintain dental hygiene to prevent pro-inflammatory gingivitis.122. it could become part of an arsenal of new stroke treatments. They aim to test whether a rapid increase in a stroke victim’s magnesium level.” “Hard” water contains more magnesium than “soft” water.118. UCLA researchers hope that if magnesium sulfate is found to help reduce the size and severity of a stroke. Los Angeles County paramedics will administer intravenous magnesium sulfate to patients being transported to the hospital. the magnesium-rich germ and bran are removed.34 MAGNESIUM TO TREAT STROKE VICTIMS Stroke patients in Los Angeles County are participating in a study to determine whether magnesium can protect the brain from damage.The nation’s leading health agency acknowledges magnesium’s critical role in keeping us alive.83-87 and other age-related disorders.36-53 Life Extension has extensively published about the dangers of chronic inflammation.54-59 Most scientists now accept that inflammation plays a role in the development of atherosclerosis. This study is being conducted under a $14-million grant from the National Institutes of Health.88-104 The best way to assess whether a person suffers from chronic inflammation is the C-reactive protein blood test.14 PAUL MASON’S MISSION CONTINUES .119 Take supplemental carnitine. or eat high-fiber diets. A new study showed that adults who consume less than the recommended amount of magnesium are 1. This government grant is crucial. drug companies have little interest in testing magnesium sulfate.123 alpha tocopherol. The NIH agreed to fund the project in 2003 after animal studies found that magnesium sulfate proved to be a powerful protector of brain tissue under assault from stroke. an inflammatory marker in the blood that predicts who is likely to suffer a heart attack or stroke.121 gamma tocopherol.34 This finding offers yet another reason why those who are magnesium deficient have increased rates of cardiovascular disease—their C-reactive protein levels are likely to be higher! Life Extension members were warned about the dangers of C-reactive protein long ago and were informed how to keep this inflammatory marker as low as possible by taking the following steps: Consume soluble fiber before heavy meals. yet the FDA has done everything it could to keep this low-cost mineral out of Americans’ bodies. Researchers believe that magnesium infusions might slow the chemical process that kills brain cells during the time before an ischemic stroke can be treated. WHICH FOODS PROVIDE MAGNESIUM? Green vegetables such as spinach are good sources of magnesium because the center of the chlorophyll molecule (which gives these vegetables their color) contains magnesium. and whole. Bread made from whole-grain wheat flour provides more magnesium than bread made from white refined flour. nuts. Half of those who participate in the study will receive a placebo consisting of saline solution and the others will get the magnesium sulfate.60-69 cancer. Water that naturally contains more minerals is described as “hard. To assess the effectiveness of the experimental treatment.120. can reduce the disability and death that so often occur during the time when the blood supply to the brain is partially cut off. When white flour is refined and processed. Refined grains are generally low in magnesium.70-82 Alzheimer’s disease.48 to 1. Higher blood levels of C-reactive protein mean greater risk of cardiovascular disease. unrefined grains are also good sources of magnesium. seeds.114-117 Keep DHEA levels in youthful ranges. Some legumes (beans and peas). MAGNESIUM DEFICIENCY ELEVATES CRP The hot new term discussed by cardiologists is C-reactive protein. researchers will compare how well participants in each group are functioning three months after their stroke.75 times more likely to have elevated C-reactive protein.105-113 Minimize consumption of pro-inflammatory foods such as saturated fats and foods cooked at high temperatures.
003345).”142 Paul Mason encourages bottlers to fortify their products with magnesium. That is. lower incidences of mortality and heart disease. According to data compiled by Paul Mason: “Even modest amounts of magnesium in water apparently reduce the rate of mortality (by an average of . Inexpensive magnesium additives with no impacts on flavor include magnesium bicarbonate. LE Magazine September 2005 . (The map tells you how to find Paul Mason’s Free Spigot. and mineral-depleted soil. If bottlers prefer to market a bottled water naturally rich in magnesium.”141 Paul Mason is telling the world that consuming more magnesium could save 21 million lives a year.After being rebuffed by the US government. The US National Academy of Sciences has estimated that a nationwide initiative to add calcium and magnesium to soft water might reduce the annual cardiovascular death rate by 150. that have indicated an inverse relationship between water hardness and mortality from cardiovascular disease. If the 68% of Americans who are magnesium deficient took corrective action.350. virtually no one emphasizes the critical importance of magnesium. the need for many of these prescription drugs would be reduced. only a few have bothered to pay attention. Purified water and soft drinks should be fortified with magnesium to match the beverages humans have historically consumed.) Click to enlarge map DOCTORS IGNORE MAGNESIUM DEFICIENCY ISSUE Doctors eagerly prescribe expensive patented drugs. Patterson CA 95363) and haul away as much free. while low-cost nutrients like magnesium remain overlooked.143 Life Extension readers are invited by Paul to bring their own bottles to the “Free Spigot” at Adobe Springs (located at 19000 Del Puerto Canyon Road. Regrettably. Adult males generally consume at least one liter of beverages per day. the RDI (recommended daily intake) for adult males is 420 mg a day. there have been more than 50 studies. often just 5-20 mg/liter. meaning that very few Americans obtain optimal amounts of magnesium. milk. HOW MUCH MAGNESIUM DO YOU NEED? For magnesium. in nine countries. the public is bombarded with advertisements encouraging people to ask their doctor for statin drugs such as Lipitor® and Zocor®. Paul will supply them with bulk water from his state-inspected Adobe Springs. magnesium-rich water as they want for personal use. grape juice. The RDI is considered a minimum daily intake. magnesium gluconate. which suggests that beverages should contain about 100 mg of magnesium per liter.240. EXCERPT FROM PAUL MASON’S WEBSITE “According to the US National Academy of Sciences (1977). Many scientists believe a higher RDI would be appropriate. but the actual dietary intake is only 327 mg a day. Instead. Paul Mason is now working with the World Health Organization to encourage adding magnesium to drinking water in other countries whose citizens suffer from diseases related to magnesium deficiency. a dietary shortfall of 93 mg a day. including orange juice. water purification that removes natural minerals. and magnesium lactate.000 in the United States.000 suggests a possible decline in mortality of 21. The reasons for such widespread magnesium deficiencies include increased consumption of processed foods. Many natural beverages contain about 100 mg of magnesium per liter. While growing numbers of cardiologists are recommending fish oil and coenzyme Q10. and some beers. which contains 110 mg of magnesium per liter. The result is that startling numbers of aging Americans suffer the lethal consequences of magnesium deficiency.750 per year—making magnesium deficiency a bigger cause of death than AIDS and war combined. people who drink water that is deficient in magnesium and calcium generally appear more susceptible to this disease. Applying that mathematical benchmark average to a world population of 6. many wines. Paul has collected 80 studies showing that small amounts of magnesium in water. some mineral spring waters.000.
6 115.242 937 679 731 500 521 428 1 2 3 4 5 6 8 Poland Spring Arrowhead Aquafina Sparkletts Evian Deer Park Zephyrhills $406.0 $246. .4 $147. The needless drag on the US economy from magnesium deficiency exceeds $86 billion per year . We even had our magnesium supplements seized by the FDA because we presented evidence that this mineral could help prevent heart attack.6 102.0% 4.0 $167. CALCULATING AMERICAN DEATHS CAUSED BY MAGNESIUM DEFICIENCY “Magnesium deficiency appears to have caused 8 million sudden coronary deaths in America during the period 1940-1994 . William Faloon Rate Your Bottled Water The table below of America’s 10 leading bottled waters shows how many lives might be saved if these brands either switched to springs that are naturally rich in magnesium or fortified their water with magnesium. Unfortunately.0 2 5 22 5 24 1 7 .2 170. For longer life. As a Life Extension member. Life Extension has recommended high-potency magnesium supplements.4% 3.4% 3.2 $315. American bottled water contains only 10% as much magnesium as bottled water in the rest of the world.4% 5. you are regularly informed about scientific discoveries that can enable you to avoid becoming a casualty of today’s broken health care system. . and American processed foods and snack foods are magnesium-deficient because processing often removes magnesium. . In the early 1980s.145 —Paul Mason We commend Paul Mason for his meticulous compilation of data showing that millions of people are dying each year from the effects of magnesium deficiency. With all the research linking low magnesium intake with high cardiovascular risks.How Many Americans Are Magnesium Deficient? DEFYING THE CRITICS Since 1981. BEVERAGE WORLD Top 10 Bottled Waters of 1999 RANK BRAND SALES (millions) MARKET SHARE ESTIMATED GALLONS (millions) MAGNESIUM mg/liter COUNTRY ESTIMATED LIVES OF SAVED ORIGIN PER YEAR if water had 90 mg/liter magnesium US US Canada US France US US 1.8 217. because magnesium is perhaps the most deficient mineral in the American diet.2% 6. Medical ignorance continues to be the number-one cause of death.8% 5. American beer contains only a fraction of the magnesium contained in European beers. the American rate of death from magnesium deficiency is likely to be above the benchmark average because the American diet is particularly magnesium deficient.5 8.0% 278.5 $219. magnesium is so cheap that virtually no one is promoting it as a lifesaving mineral. Those who follow our basic supplement program obtain 325665 mg of supplemental magnesium each day.0 $285.6 197. the Life Extension Foundation was criticized by mainstream doctors for recommending high doses of magnesium relative to calcium.0 149. this low-cost mineral would appear to be a simple way to counter today’s heart attack and stroke epidemic. We view Paul as an unsung hero for his battle to enlighten the world about these startling statistics. Perhaps one day the medical community will listen. .
Weinberg M. Brush B. Goiter prevention with iodized salt: results of a thirty-year study. et al. Silver B. Dietary modulators of blood pressure in hypertension. Korsholm T. Maier J. Arterioscler Thromb Vasc Biol. Malpuech-Brugere C. 12. 1987 Feb. . Am J Clin Nutr. Paul W. Mason. Michael Friedman. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis. 1990 Sep.cfm?id=DS00217. 13.032 The bottled water with the highest magnesium content (110 mg/liter) is sold under the brand name “Noah’s Spring Water. Biochim Biophys Acta.9 10 Ozarka Hinckley Springs* TOP 10 BRANDS All Brands $144. Fisher M. Folsom A. blood pressure. Mazur A.21(5):858-62.216. 2005. Low magnesium and atherosclerosis: an evidence-based link. Peacock J.8 $4. Tanabe K. Rastogi S. 2004 May 24.” Unfortunately. The efficiency and safety of the prevention of goiter. Singh R. Singh R.400. 1999 Apr.2 $2.org /idd. Hennekens C. Northern District of California. District Court of The United States. Effects of intravenous MAGNESIUM sulfate on arrhythmias in patients with congestive heart failure. NOTE: Sales figures preliminary. 15. Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. 8.24(1-3):137-46.12 (10):1380-8. Clin Cardiol. Eckfeldt J. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Falk E. C97-20686 RMW.900. 17. Zimowska W. and hypertension among US women. 9. 1928 91:454-60.7% 44.308 15.27(5):1065-72. Shechter M.125(6):1645-50. Willett W. 2. Pressel M. Greenberg N.9(3):159-65. Rayssiguier Y.526. Circulation. Plaintiff vs.85 Suppl 6:135-45.9% 2. 11. 7. Patten R. Accessed June 6. Noda K. CASE NO. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study.0 1 ? 8.6 3.0 2. 1996 May. 2005. inflammation and thrombosis. 1952 Oct.44 (4):319-27. 2000 Nov 7. 1996. Secretary of Health and Human Services. Forrester J.6 91. J Clin Endocrinol Metab.0% 98.S. Reed DM. Magnesium in supraventricular and ventricular arrhythmias. Defendants. Bairey Merz C.8 1. distribution of this brand of bottled water is limited to certain parts of California. and Dr. Szklo M. Kimball OP. 2001 May.45(2):469-75. 1990 Apr. Z Kardiol.1689(1):13-21. Joffres MR. 6. References 1. SOURCE: Beverage Marketing Corporation. Accessed June 6. 1993 Jun. Available at: http://www. Am Heart J. Sharir M.saltinstitute. 2003 Feb-Jun. Gottlieb S. Altland J. Available at: http://www.9% 100.mayoclinic. Yano K. JAMA.6 $134. et al. Accessed June 6. Ascherio A. 10. Acting Commissioner of the U. 3. Labrador M. 16.102(19):2353-8. Arnett D. Food and Drug Administration. Zehender M. Kamegai M. Ann Epidemiol. Sircar A. Maier J.13 (9):663-5. Variant angina due to deficiency of intracellular magnesium.com/invoke. Eur J Clin Nutr.144 *Formerly known as Hinckley & Schmitt.4 mg/L 2. Available at: http://www. Mol Aspects Med.mgwater.html. Ravn H. 14. 4. Donna Shalala. 5.com. 2005. Prospective study of nutritional factors. Hypertension.7 mg/L US US 80% US Mostly US 444 ? 6.
Leary W. Neuenfeld H. Boyko V. Cardiovasc Drugs Ther. acute myocardial infarction and reperfusion injury.mgwater. Pachinger O. 2005 Mar. Woolson R. Chouraqui P. Shen M.18. Manson JE. 2005. Rabinowitz B. 2005 Jun 24(3):166-71.106(10):1224-8. Schmitz C.shtml.asp. Accessed June 6. Yang C. Levy D. R. Shechter M. 21. .asp. Shechter M.288(8):980-7. 22. Geesey M. 2002 Aug 28. and quality of life in patients with coronary artery disease. et al. Whang R. Toft G. Sironi L. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. 2005. C-reactive protein (CRP) in the cardiovascular system. Sheu J. Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients. Hsiao G. Kanda T. Tsai S. Cardiology. Smetana R.com/ heart. Rabinowitz B. Am J Cardiol. 20. Perraud A. and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. Magnesium. Chen C. 1983 Oct 22. Am Heart J. Magnesium and sudden death. et al. Thromb Haemost. Ravn H. Lee Y. Dietary magnesium and C-reactive protein levels. Available at: http://www. 1998 Jan. S Afr Med J. Cell. JAMA. Johnson C. 31. Tremoli E. Tedeschi L. Accessed June 6.seattlechildrens. 23. 2003 May.15(2):261-4. 2003 Jul 25. 32. Compr Ther. Magnesium inhibits arterial thrombi after vascular injury in rat: in vivo impairment of coagulation.nih. Circulation. 2002 Sep 3. Effects of oral magnesium therapy on exercise tolerance. Calvio A.150(15-16):343-7. Relationship between magnesium levels in drinking water and sudden infant death syndrome. 27. 39. 38. Decensi A.18(1):12-8. Yen M. Omodei U. Hjortdal V. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. 2002 Sep 3.99(4):205-10. Robertson C. Mainous A 3rd. Douban S.12 Suppl 2:153-6. 33. Wu T. Wang TJ. Antithrombotic effects of magnesium sulfate in in vivo experiments. Whang. Jester H. Whang D. 2000 Jul 1. Larson MG. Mussoni L. Brodsky M. The role of magnesium as antithrombotic therapy. 34. 24. Hod H. Wink K. Intravenously and topically applied magnesium in the prevention of arterial thrombosis.gov/factsheets/magnesium. Folsom A. Am Heart J. hormone replacement therapy. Liao F. Available at: http://www. Magnes Res. Shechter M. Chiu H. et al. et al. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study.49(4):395-401. Wien Med Wochenschr. Rossouw JE. 2003. 2003 Mar 1.86(5):1292-5. Reyes A. 1996 Sep.114(2):191-200.132(3):664-71.99(1):61-9. Significance of magnesium in congestive heart failure. 37. Bairey Merz C.91(5):517-21. 2005 Feb. J Am Coll Nutr. 29. 35. Circulation. Stuehlinger H. 1998 Sep.64(18):697-8.24(1):5-8. Brancati F. Inflammatory biomarkers. Pradhan AD. Effects of magnesium orotate on exercise tolerance in patients with coronary heart disease. Stergiou N.77(4):414-9. King D. 25.org/ home/about_childrens/press_releases/000100. Int J Hematol. Geiss K. Rinsho Byori. Colli S. Available at: http://ods.od.106(10):1189-91. 2005. Accessed June 6. 2001 Apr. 1998 Sep. Clin Calcium. Slany J. exercise-induced chest pain. 2000. 30. 2001 Nov. 28.136(3):480-90. 26. Electrolyte and water metabolism in sports activities. 36. Thromb Res. 19. Jester.
50.lef. cardiovascular mortality and cardiovascular risk factors in men. Freijo-Guerrero MM. Hennekens CH. 2003 Jan. Sadaba-Garay F.43(6):607-19. 2000 Oct 31. 59.35(5):452-62. Pasceri V. 44.40. Stampfer MJ. 62. 2002 Nov.134(1-2):142-50. 2000 Nov. 45. 1998 Feb 10. 41. inflammation and thrombosis. van Boxtel MP. J Cardiovasc Risk.org/magazine/ mag2000/mar00-report. Inflammation markers in relation to cognition in a healthy aging population. Papa F. 42.html. Fuster V. Accessed June 6. Accessed June 6. Obesity and low-grade systemic inflammation. Inflammatory mechanisms. 2005. Tracy RP. 51. Cushman M. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Corti R. Circulation. 58. Available at: http://www. 52. C-reactive protein and coronary artery disease.336(14):973-9. 49.102(18):2165-8. C-reactive protein and carotid intimal medial thickness in a community population. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Badimon JJ. Inflammation. N Engl J Med.27(3):209-14. 2002 Sep. 2005. C-reactive protein: relation to total mortality. Willerson JT. Accessed June 6. Tracy RP.org/magazine/ mag2002/jan2002_awsi_01. 1999 May. 43. J Thromb Thrombolysis. Invitti C. Accessed June 6. Ferrucci L. J Neuroimmunol.17(1):35-44. Tracy RP. 2001 Apr 3. 53. C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention. Rev Neurol. et al. Circulation. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Ridker PM. 1997 Apr 3. et al. Hennekens CH. Rifai N.html. et al. Available at: http://www. Teunissen CE.98(8):731-3.32(1):133-8. Cardiovasc Toxicol. 2001 Mar.106(5):506-12. Bocola V. Accessed June 6. Hutter R. 2002 Apr. Mendall MA. Eber B. Available at: http://www. and the risk of cardiovascular disease in apparently healthy men. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.org/magazine/ mag2001/jan2001_awsi. Ridker PM.lef. Clin Chem. Lassnig E. et al. Brod SA. Cushman M. 2002 Sep 1. Evolving concepts in the triad of atherosclerosis. Rifai N. arteriosclerosis and ischemic stroke: clinical data and perspectives.html. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.9(2):97-103. Yeh ET. Jpn Heart J. 60.1(2):153-7. Buring JE. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Stroke. 2005. Berent R. Circulation. 2005. Eur Heart J. 2000 Oct. . Inflamm Res. 56. Hennekens CH. aspirin.lef.lef. 2001 Jan. 55.org/magazine/ mag2001/jan2001_itn. Matias M. Ridker PM. Shih J. Available at: http://www.lef. 54. Ridker PM. Strachan DP. 47. 2001. Markus HS. Bosma H.html.html. Ridker PM.103(13):1813-8.49(11):561-70.html. Mendall MA. 57. Sitzer M. Alvaro-Gonzalez LC. Unregulated inflammation shortens human functional longevity. 48. 46. 2005.org/magazine/ mag2000/july2000_itn. Am J Med. Minerva Endocrinol.97(5):425-8. Accessed June 6.47(3):403-11.org/magazine/ mag2000/feb00-report2.lef. 2005. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Circulation. Butland BK.21(19):1584-90. 61. Stampfer MJ. Auer J. Available at: http://www. 1998 Aug 25. Available at: http://www. Harris TB. Di Napoli M. 2004 Feb.
Weitzman SA. Seed MP. N Engl J Med. Am J Med. 1989 Sep. Fox LA. Adami HO. Brouqui P. Banks WA. Eur Heart J. Wink D. N Engl J Med.90(12):1279-83. Sheldon J. Deeb ZE. 1997 Mar. McGann K. Mulshine JL. Packard CJ. 78. 70. Zavros Y. 69. Oncogene. 68. Mancini E. 71. 73. Clin Cancer Res. FASEB J. 72. 1997 May. Chronic inflammation and cancer. Risk factors for biliary tract carcinogenesis. The potential contributions of chronic inflammation to lung carcinogenesis. 2002 Feb.97(5):451-8. 1999. Stetler CA. Jackson JR. 81. Irving SD. Possible role of ovarian epithelial inflammation in ovarian cancer. Biochem J.323(18):1228-33. 2002 Dec 15. The codependence of angiogenesis and chronic inflammation.18(3):470-9. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina.14 Suppl 1:3-9. Scholz D. The association of chronic inflammatory disease in lichen planus with cancer of the oral cavity. 77. Howe GR. Carney RM. Cancer Epidemiol Biomarkers Prev. Grisham M. Biochemistry (Mosc. Klovekorn WP. Raoult D. Eaton KA. et al. Willoughby DA. West of Scotland Coronary Prevention Study Group. 2000 Apr. Kaski JC. Lindahl B. Wenk GL. 1990 Nov 1. 2000 Oct 19. 1994 Nov.4(5):447-51. Winkler JD. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. 74.91 (17):1459-67. Thomas GR. Nephrol Dial Transplant. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Ballaz S. Maeda H. Circulation. inflammation. et al. Miller GE. 1999 Sep 1. Malhotra PS. Ann Oncol. Cole D. 65. 2003 Jul. Review article: chronic inflammation and reactive oxygen and nitrogen metabolism— implications in DNA damage and mutagenesis. 75. FRISC Study Group.63.343(16):1148-55. Clin Lung Cancer. Chapman RW. Ekbom A. 66. J Natl Cancer Inst. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Devaux B. Oncology (Williston Park). 82. A population-based study. 79. 64. Dumler JS. Cardiac effects of chronic inflammation in dialysis patients. Zack M. Siegbahn A. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. 83. Caslake MJ. Cottreau C. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure.10(5):314-6.10 Suppl 4:308-11. Wiseman H. 2005 Mar 31. Helmick C. Kircher CH. Jourd’heuil D. Risch HA. N Engl J Med. 67. Ulcerative colitis and colorectal cancer. O’Reilly DS. Shacter E.313 (Pt 1)17-29.63(7):854-65.5(1):46-62. Immunohistologic demonstration of Coxiella burnetii in the valves of patients with Q fever endocarditis. 2001 Aug 14. Am J Otolaryngol.16(2):217-26. Smith DA. Clinical depression and inflammatory risk markers for coronary heart disease.5(6):1369-79. 1999 Jun. Toss H. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. 1995 Jul. Halliwell B.17 Suppl 8:10-15. Fragmin during Instability in Coronary Artery Disease.343(16):1139-47.24(14):2354-66. 2000 Oct 19. Schaper J. Akaike T. Markers of myocardial damage and inflammation in relation to longterm mortality in unstable coronary artery disease. Am J Cardiol. and cancer. 80. Venge P. deFries HO. Chen Z. Ness RB. 2002. Kang W. Hauss-Wegrzyniak B. Nitric oxide and oxygen radicals in infection. Rosi S.). Freedland KE.104(7):746-9. et al.11(6):457-65. Wallentin L. 76. 1996 Jan 1. 229. 1998 Jul. The toxicity of tumor necrosis factor-alpha upon cholinergic neurons . Aliment Pharmacol Ther. Santoro A. Hirche A.
Glabinski AR. Tyrrell PJ. Emsley HC.24(7):383-6. Inflammation and degeneration in multiple sclerosis. Folstein MF. Metabolic consequences of inflammation in kidney failure. Mol Psychiatry. J Neurosci Res. 2002 Nov 11.2(4):353-60. McBurnie MA. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. 96. Shiels IA.24 Suppl 5:S265-7. 1989. 2003 Jul 19. Bruck W. Hauss-Wegrzyniak B.54(2):193-7. and contribute to neurotoxicity and neuroprotection. Samii A. Tai K. Neuroscience. 85. 2000 Feb. Van der Meide PH. Holman BJ. 1995 Jan. Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease. Schmidt R. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. Biotherapy. 98. et al. 89. Selmaj K. Ahmed S. Tomita M. estrogen use with reduced Alzheimer risk. Ransohoff RM.162(20):2333-41. 2003. 91. 93. Proudfoot AE.121(3):719-29. Neurology. 1996. Fouque D. Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial . Santoro TJ.1(4):369-75. et al. Neuroscience. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms. et al.275(18):1389-90. 1999 Jul. 1992 Feb. Blaser MJ. Gastroenterology. Pang KC. J Immunol. 2002 Dec. 99. Rich JB. 2001 Apr 1. 2001.4(4):317-27. 100.64(1):26-33.8(3-4):243-9.22(12):1399-419. et al. Rheum Dis Clin North Am. 86. Ajuebor MN. Nephrologie. BMJ. 2003 Dec. Walston J. 90. Kunkel SL. 95. Inflammation and infection in clinical stroke.327(7407):128. Neurol Sci. 2000. CXC chemokine receptors expression during chronic relapsing experimental autoimmune encephalomyelitis. 102. De Vos M. Licinio J.917:135-44. Wallace JL. More evidence links NSAID. Stephenson J. Bowel inflammation and the spondyloarthropathies. Mishra A. Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. Biol Neonate. Schellekens H. et al. 87. Rasmusson DX. Willard LB. 103. et al. 2001 Apr. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. 1999 Jan. Brandt EB. Wenk GL. 101. 92. Biotherapy.24(4):785-813.52(2):168-74. Wong ML. 88. Nat Immunol. Gill S. Newman A. Elewaut D. Guebre-Egziabher F.102(2):720-7. regulate stress-responsive systems. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med.166(1):552-8. Taylor SM. 2002 Aug. Cominelli F. Williams LS. Fairlie DP. Cytokines and the immune response. Curb JD.within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer’s disease. Hogaboam CM. 1998 Nov. Schmidt H. 2003. O’Bryant S. Speer CP. J Cereb Blood Flow Metab. Stadelmann C. De Keyser F. Etminan M. 97. JAMA. Dinarello CA. 104.88(1):193-200. Cell phenotype as a target of drug therapy in chronic inflammatory diseases. 94. 2001 Jan 1. Deon D. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Med Hypotheses. 1996 May 8. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer’s disease: systematic review and meta-analysis of observational studies. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.79(3-4):2059. 84. New insights into the pathogenesis of pulmonary inflammation in preterm infants.45(1):51-5. Ann NY Acad Sci. Ann Neurol. Hogan SP.
53(11):1454-61. Fan Z. type 2 diabetes. 2004. Goldner WS. Rifai N. et al. Semin Nephrol.13(Suppl):S106. 2004 Dec 21. 107.55 (6):589-612. Mikhailidis DP. et al. Angiology. Andersen RN.17(8):765-75. Casson PR. 2004 Aug.169(6):1536-9.44(10):2003-7. 120. 2004 May. Putz DM.110(25):3842-8. 1999 Dec. 122. Circulation.290(4):502-10. 123. et al. Daskalopoulou SS. et al. Salmenniemi U.15(1):13-7. and adhesion molecules in subjects with metabolic syndrome. Savica V. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. Brenner T. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Gamma-tocopherol. Sella R. Kidney Int. 2003 Sep. Dwyer KM. 116. Jenkins DJ.62 (6):283-7. Rassoul F. Sheikh-Ahmad M. Wu H. Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. Relation of dietary fat and fiber to elevation of C-reactive protein. Mokdad AH. CRP levels and insulin resistance. Jiang Q. Int J Dev Neurosci. 1993 Dec. Himmelfarb J. Savarese G. Effects of diet modification on cardiovascular risk: results from the leipzig wholesome nutrition study. Aronson D. Kane J. Am J Cardiol. 2003 Jul 23.292(20):2482-90. Elisaf M. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome. Tuzcu A. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. et al. 119. Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 [correction of interlukin-6] in astrocytes. JAMA. Ford ES.134(5):1181-5. decreases proinflammatory eicosanoids and inflammation damage in rats. 110. JAMA. Metabolism. 2004 Nov 24. 2004 Dec. Am J Obstet Gynecol. McCarty MF. . et al. et al. 111. 2004 Nov. Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. J Immunol. King DE. Santoro D. Benatti P.64(3):978-91. 115. Ludwig DS. Haynes WG. Horm Res. Savica V. 2003 Dec 1. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study.24(5):464-8. Sivitz WI. 2001 Nov 1. et al. Goldfine AB.92(11):1335-9. Adiponectin and C-reactive protein in obesity. Calvani M. Swain J. 105. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. 112 . Geesey ME. Galilly R. 2004 Nov 16. Bar RS. 108. J Am Coll Cardiol. Ames BN. 118. Kendall CW. Med Hypotheses. 2004 Sep. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. Asia Pac J Clin Nutr. Low-insulin-response diets may decrease plasma C-reactive protein by influencing adipocyte function. et al. J Nutr. and effect of bicalutamide on hirsutism. Schillaci G. Pirro M. Calvani M. FASEB J. Eur J Cardiovasc Prev Rehabil.17(8):816-22. Bellinghieri G. 2005 Jan. Prevention and treatment of the metabolic syndrome. Bahceci M. 121. McMonagle E. Kipper-Galperin M. 2003 Dec. but not alpha-tocopherol.64(2):385-7. Am J Clin Nutr. Danenberg HD. Pihlajamaki J. Egan BM. 113. 2004 Nov. Herrod HG.11(6):497-502. J Ren Nutr. Ajani UA. Marchie A. cytokines. 117. 106.78(6):1085-91. Pereira MA. 114. Richter V. 2005. et al. 109. 2003 May. and monodrug therapy. Purschwitz K. Ruotsalainen E.fibroblasts. Canoruc N.167(9):5395-403. Carnitine system in uremic patients: molecular and clinical aspects.
Devaraj S. Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. J Nutr Biochem. Am J Cardiol.21(10):749-55. .29(8):790-2. Effect of supplementation with tomato juice. Weight reduction. vitamin E. A review of the literature. Available at: http://www. Marchioli R. 127.com/features/health/la-he stroke28mar28. Uzick M. Murphy RT. 126. and olive oil polyphenols. Diabetes Care. 2001 Jun. Accessed June 6. Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes. Schulze MB. 140. Available at: www. Skou HA.23(6):733-8. Devaraj S. J Nutr. and the extent of coronary artery disease. 137. Compend Contin Educ Dent. Bomba E.3986403.88(10):1139-42. Wang XL. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Available at: http://www.mgwater. 2005. 143. 2005. Rainwater DL. 2004 Sep. Eur J Clin Invest. Lee YS. and diabetic vasculopathies: the role of alpha tocopherol therapy. 2004 Sep. 130. Ciubotaru I. Lopez-Garcia E. Plat J.134(7):1806-11. Foley JB. lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Jellema A.latimes. Mahaney MC.com/waters.108(2):155-60. Nestel P. Chin JP. Wander RC. Mensink RP. 2000 Oct 15. Free Radic Biol Med. Accessed June 6.80(3):649-55. alpha-tocopherol. 141. Free Radic Res. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. 142. and triacylglycerol to HDLcholesterol ratio in postmenopausal women on HRT. 2004 Nov. 2004 Jul. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.com/adobe. et al. Accessed June 6. 139. Tome MT. 134.story?ctrack=1&cset=true. 2005.36(8):959-65. Jialal I. The periodontal-cardiovascular link. 2005. 2001 Nov 15. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. 1994 Oct. Mann JI. et al.80(5):1137-44. Stocker R. dietary n-3 fatty acids.6(3):248-71. Dietary fish oil decreases C-reactive protein. HBPRCA Astra Award.34 (11):766-73.25(9):681-92. 2002 Dec.14(9):513-21.shtml. red yeast rice.mgwater. Pomeroy S.36(12):1331-6. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils. 2004 Apr 15.mgwater. 2003 Jul 15. et al. 125. Circulation. C-reactive protein. Madsen T. 136. Free Radic Biol Med. 138. et al. 2004 Nov. Trebble TM. Oxidative stress. 131. Venugopal SK. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors. Wootton SA. 2002 Aug. Patrick L. 144. Barzi F. Altern Med Rev. Pischon T. inflammation. Jialal I. Hankinson SE. Available at: http://www. Shige H. Am J Clin Nutr.com/calcs. Manson JE. et al. but not a moderate intake of fish oil.76(2):326-30. Arden NK. et al. Accessed June 6. Hotamisligil GS.shtml. Accessed June 6.com.124.shtml#summary. Dart AM.mgwater. interleukin-6. 129. Paquette DW. Sutherland WH. and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. et al. 2000 Jun. Available at: http://www. Clin Exp Pharmacol Physiol. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Upritchard JE. Am J Clin Nutr. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr. Circulation. 2005.1. 2003 Sep.105(16):1897-903. 133. 128. 2002 Apr 23. 135. 132. Hansen VE.
or if you have or suspect you might have a health problem.145. All Contents Copyright © 1995-2013 Life Extension® All rights reserved. exercise or supplementation program. Accessed June 6. treat. Available at: http://www.mgwater. 2005. You should consult with a healthcare professional before starting any diet. These statements have not been evaluated by the Food and Drug Administration. cure or prevent any disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not stop taking any medication without first consulting your physician. .shtml. before taking any medication. These products are not intended to diagnose.com/calcs. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue reading from where you left off, or restart the preview.